Voyager Therapeutics VYGR
NASDAQ VYGR
$2.45 -0.22 (-8.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Cash & Current Investments (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded Cash & Current Investments of $116.34 million in Q2 2026, down 46.0% from $215.59 million a year earlier and down 17.8% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Cash & Current Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, Voyager Therapeutics reported Cash & Current Investments of $196.45 million, down 26.3% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $266.68 million in FY2024 (+15.5%), $230.88 million in FY2023 (+94.3%), $118.85 million in FY2022 (-10.3%) and $132.54 million in FY2021 (-26.8%).
  • The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q3 2015.
  • On a year-over-year basis, Cash & Current Investments has declined for six consecutive quarters, with an average decline of 22.8% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 94.3% in Q4 2023, against a decline of 46.0% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $141.48 million (Q1 2026), $196.45 million (Q4 2025) and $208.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Voyager Therapeutics 150.12 Mn -513.07 Mn - 116.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.34 Mn
Mar 31, 2026 141.48 Mn
Dec 31, 2025 196.45 Mn
Sep 30, 2025 208.93 Mn
Jun 30, 2025 215.59 Mn
Mar 31, 2025 236.02 Mn
Dec 31, 2024 266.68 Mn
Sep 30, 2024 345.36 Mn
Jun 30, 2024 371.02 Mn
Mar 31, 2024 399.57 Mn
Dec 31, 2023 230.88 Mn
Sep 30, 2023 252.94 Mn
Jun 30, 2023 272.75 Mn
Mar 31, 2023 273.31 Mn
Dec 31, 2022 118.85 Mn
Sep 30, 2022 131.64 Mn
Jun 30, 2022 148.06 Mn
Mar 31, 2022 166.83 Mn
Dec 31, 2021 132.54 Mn
Sep 30, 2021 121.50 Mn
API Access

Voyager Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VYGR&period=max&api_key=YOUR_API_KEY